IMPLICATIONS OF PROTEINURIA REMISSION ON ESTIMATED GLOMERULAR FILTRATION RATE (eGFR) TRAJECTORY IN PATIENTS (Pts) WITH IgA NEPHROPATHY (IgAN) IN PROTECT

Back

Abstract Title *

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than January 23, 2025. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.

E-Poster Format Requirements

PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos

E-Poster

https://storage.unitedwebnetwork.com/files/1099/7fd7ab72e54030ae423eedd3dfe2c6b1.pdf

First Name *

Bruce

Last Name *

Hendry

Number of Co-Authors

Co-author 1

Hiddo J L Heerspink h.j.lambers.heerspink@umcg.nl Department of Clinical Pharmacy and Pharmacology University of Groningen, Groningen, the Netherlands; The George Institute for Global Health, University of New South Wales Sydney Australia

Co-author 2

Vladimir Tesar Vladimir.Tesar@vfn.cz Department of Nephrology General University Hospital, Charles University Prague Czech Republic

Co-author 3

Radko Komers radko.komers@travere.com Travere Therapeutics, Inc. Clinical Development, Nephrology San Diego United States

Co-author 4

Priscila Preciado Priscila.preciado@travere.com Travere Therapeutics, Inc. Clinical Development, Nephrology San Diego United States

Co-author 5

Edward Murphy Edward.Murphy@travere.com Travere Therapeutics, Inc. Biostatistics San Diego United States

Co-author 6

Brad Rovin brad.rovin@osumc.edu Ohio State University Wexner Medical Center Division of Nephrology Columbus United States

Co-author 7

Co-author 8

Co-author 9

Co-author 10

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15

Co-author 16